Log in
|
Specification |
Details |
|
Test Type |
14-Panel Urine Drug Test Cup |
|
Test Format |
Integrated Collection Cup |
|
Sample Type |
Human Urine |
|
Technology |
Rapid Immunoassay |
|
Time to Results |
Approximately 5 Minutes |
|
Classification |
CLIA Waived |
|
Intended Use |
Professional Point-of-Care Testing |
|
Specification |
Details |
|
Test Type |
14-Panel Urine Drug Test Cup |
|
Test Format |
Integrated Collection Cup |
|
Sample Type |
Human Urine |
|
Technology |
Rapid Immunoassay |
|
Time to Results |
Approximately 5 Minutes |
|
Classification |
CLIA Waived |
|
Intended Use |
Professional Point-of-Care Testing |
The 14-Panel Urine Drug Test Cup offers comprehensive screening for a broad range of commonly abused and prescription drugs while providing the added benefit of EDDP (Methadone Metabolite) detection. By screening for both Methadone (MTD) and its primary metabolite EDDP, the test supports more effective monitoring of medication-assisted treatment (MAT) programs, pain management patients, and compliance testing.
Its integrated collection and testing design streamlines the screening process, minimizes specimen handling, and delivers dependable preliminary results in approximately 5 minutes. With its broad drug panel, user-friendly operation, and CLIA Waived classification, this test cup is an excellent choice for workplace drug testing, healthcare facilities, rehabilitation centers, correctional institutions, and forensic laboratories
The 14-Panel Urine Drug Test Cup is designed to detect 14 commonly abused and prescription drugs using human urine specimens. This comprehensive testing panel supports workplace drug testing, healthcare facilities, rehabilitation programs, pain management clinics, compliance monitoring, occupational health services, and forensic applications.
Below is general educational information about each drug included in this testing panel
Amphetamine is a prescription central nervous system stimulant commonly prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy. It works by increasing dopamine and norepinephrine levels in the brain, helping improve concentration, focus, and alertness.
Although amphetamine has legitimate medical uses, it is also frequently misused for its stimulating effects. Repeated misuse may result in dependence, cardiovascular complications, and mental health disorders.
Increased energy and alertness
Improved concentration
Reduced appetite
Increased heart rate
Elevated blood pressure
Restlessness
Anxiety
Insomnia
Long-term misuse may increase the risk of addiction, paranoia, mood disorders, and cardiovascular disease.
Street Names: Speed, Uppers, Bennies, Pep Pills, Black Beauties.
Amphetamine is generally detectable in urine for 2–4 days, although frequent users may remain positive for a longer period
Barbiturates are prescription medications that depress the central nervous system. They have historically been prescribed for anxiety, insomnia, seizure disorders, and anesthesia, although safer alternatives have largely replaced them for routine treatment.
Because barbiturates can cause dependence and overdose when misused, they remain an important component of professional drug screening programs.
Relaxation
Drowsiness
Reduced anxiety
Poor coordination
Slowed reaction time
Confusion
Slurred speech
Respiratory depression
Long-term misuse may result in dependence, overdose, and severe withdrawal symptoms.
Prescription Brands: Seconal®, Nembutal®, Luminal®, Amytal®
Street Names: Barbs, Downers, Reds, Blue Birds, Yellow Jackets.
Barbiturates are generally detectable in urine for 2–15 days, depending on the specific medication and frequency of use
Benzodiazepines are prescription medications used to treat anxiety disorders, panic attacks, insomnia, seizure disorders, and muscle spasms. They produce calming and sedative effects by slowing activity within the central nervous system.
Due to their widespread medical use and potential for misuse, benzodiazepines are routinely included in workplace, healthcare, rehabilitation, and forensic drug testing panels.
Relaxation
Reduced anxiety
Drowsiness
Muscle relaxation
Slowed reaction time
Dizziness
Poor coordination
Memory impairment
Long-term misuse may increase the risk of dependence, withdrawal symptoms, and impaired cognitive function.
Street Names: Benzos, Bars, Xannies, Downers, Tranks.
Amphetamine is generally detectable in urine for 2–4 days, although long-acting medications may remain detectable for several weeks.
Buprenorphine is a prescription opioid medication widely used in Medication-Assisted Treatment (MAT) programs for opioid dependence. As a partial opioid agonist, it helps reduce withdrawal symptoms and cravings while presenting a lower risk of misuse than many full opioid agonists.
Healthcare providers frequently monitor buprenorphine therapy to support treatment compliance and long-term recovery, making it an important analyte in many professional drug screening programs.
Relief from opioid withdrawal symptoms
Reduced opioid cravings
Pain relief
Drowsiness
Dizziness
Nausea
Constipation
Mild sedation
Misuse or combining buprenorphine with other central nervous system depressants may increase the risk of respiratory depression.
Buprenorphine is generally detectable in urine for 3–7 days, depending on dosage, frequency of use, metabolism, and individual health factors.
Cocaine is a powerful central nervous system stimulant derived from the leaves of the coca plant. Although it has limited medical use in certain specialized procedures, it is primarily known as an illicit drug with a high potential for abuse and addiction. Cocaine produces an intense but short-lived feeling of euphoria by increasing dopamine levels in the brain, often leading users to take repeated doses.
People commonly use cocaine by snorting, smoking crack cocaine, or injecting it intravenously. Repeated use can rapidly lead to physical and psychological dependence.
Increased energy and alertness
Euphoria and overconfidence
Rapid heart rate
Elevated blood pressure
Decreased appetite
Anxiety and irritability
Restlessness
Strong drug cravings after the effects wear off
Long-term abuse may increase the risk of heart attack, stroke, depression, memory problems, and substance use disorder.
Coke, Blow, Snow, Flake, Crack, Rock, Yayo, Nose Candy, White, Dust.
Cocaine metabolites are typically detectable in urine for 2–4 days after occasional use, although chronic or heavy users may remain positive for a longer period
Methamphetamine is a powerful and highly addictive central nervous system stimulant that affects the brain and nervous system. While it has limited prescription use for certain medical conditions, it is more commonly associated with illicit manufacturing and abuse.
Methamphetamine produces intense feelings of energy, alertness, and euphoria by increasing dopamine levels in the brain. Repeated use can lead to severe physical dependence, mental health disorders, and long-term neurological damage.
Increased energy and alertness
Intense euphoria
Rapid heart rate
Elevated blood pressure
Reduced appetite
Insomnia
Agitation and aggressive behavior
Anxiety and paranoia
Long-term abuse may result in severe dental problems, weight loss, memory impairment, hallucinations, and psychosis.
Meth, Crystal Meth, Ice, Glass, Crank, Tina, Speed, Chalk.
Methamphetamine is generally detectable in urine for 2–5 days, depending on dosage, frequency of use, and individual metabolism
MDMA (3,4-Methylenedioxymethamphetamine) is a synthetic psychoactive drug commonly known as Ecstasy or Molly.
It possesses both stimulant and hallucinogenic properties, producing increased energy, emotional warmth, and altered sensory perception.
Although MDMA has been researched for certain therapeutic applications under controlled clinical settings, recreational use remains illegal in many countries because of its potential for abuse and harmful health effects.
Increased energy
Euphoria
Enhanced emotional closeness
Heightened sensory perception
Increased heart rate
Jaw clenching
Sweating
Dehydration
Heavy or repeated use may increase the risk of anxiety, depression, memory impairment, and heat-related illness.
Ecstasy, Molly, E, XTC, Beans, Adam, Rolls.
MDMA is generally detectable in urine for 2–4 days after use, although detection time may vary depending on dosage and individual metabolism
Methadone is a long-acting synthetic opioid medication prescribed to treat chronic pain and opioid use disorder. It is widely used in Medication-Assisted Treatment (MAT) programs to help reduce opioid withdrawal symptoms and cravings while supporting long-term recovery.
Although methadone is an effective prescription medication when taken as directed, it also has the potential for misuse and dependence. Because of this, methadone is routinely included in workplace, healthcare, rehabilitation, pain management, and compliance drug testing programs.
Pain relief
Reduced opioid cravings
Drowsiness
Dizziness
Nausea
Constipation
Slowed breathing
Sedation
Misuse may increase the risk of respiratory depression, overdose, and physical dependence.
Methadone is generally detectable in urine for 3–10 days, depending on dosage, treatment duration, metabolism, and individual health factors.
Morphine is a prescription opioid analgesic used to relieve moderate to severe pain. It belongs to the opiate family, which includes naturally occurring substances derived from the opium poppy, such as morphine and codeine. Drug screening for opiates may also detect metabolites associated with heroin use.
Although opioids are highly effective for pain management when prescribed appropriately, they also carry a significant risk of misuse, dependence, and addiction. Opiate testing is therefore an important component of workplace, clinical, rehabilitation, pain management, and forensic drug screening programs.
Pain relief
Relaxation
Drowsiness
Euphoria
Constricted pupils
Slowed breathing
Nausea
Constipation
Long-term misuse may increase the risk of opioid dependence, respiratory depression, overdose, and opioid use disorder.
Prescription Brands: MS Contin®, Kadian®, Roxanol®, Avinza®
Street Names: Smack, H, Dope, Junk, China White, Mud.
Morphine and other opiates are generally detectable in urine for 2–4 days, although chronic users may remain positive for a longer period
Oxycodone is a prescription opioid medication commonly used to treat moderate to severe pain. It works by binding to opioid receptors in the brain, helping reduce pain perception and improve patient comfort following surgery, injury, or chronic pain conditions.
Despite its legitimate medical use, oxycodone has a high potential for misuse and dependence. It is one of the most frequently monitored prescription opioids in professional drug testing programs.
Pain relief
Relaxation
Drowsiness
Euphoria
Dizziness
Slowed breathing
Nausea
Constipation
Long-term misuse may increase the risk of addiction, overdose, respiratory depression, and opioid dependence.
Street Names: Oxy, Roxies, OC, Hillbilly Heroin, Blues.
Oxycodone is generally detectable in urine for 2–4 days, depending on dosage, metabolism, frequency of use, and individual health factors
Phencyclidine, commonly known as PCP, is a dissociative drug originally developed as an intravenous anesthetic. Due to its severe psychological side effects, it is no longer approved for routine medical use in humans.
PCP affects the central nervous system by disrupting normal brain signaling, resulting in altered perception, mood, and behavior. Because of its unpredictable effects and abuse potential, PCP remains an important substance included in workplace, clinical, and forensic drug testing panels.
Hallucinations
Confusion
Loss of coordination
Numbness
Agitation
Elevated blood pressure
Rapid eye movements
Aggressive or violent behavior
Heavy use may lead to psychosis, seizures, coma, or other life-threatening medical complications.
Angel Dust, Rocket Fuel, Love Boat, Hog, Embalming Fluid, Ozone.
PCP is generally detectable in urine for 5–8 days, although frequent or chronic users may remain positive for two weeks or longer
Tricyclic Antidepressants (TCAs) are a class of prescription medications primarily used to treat depression. They may also be prescribed for chronic pain, migraine prevention, obsessive-compulsive disorder (OCD), certain anxiety disorders, and some nerve pain conditions.
Although newer antidepressants are more commonly prescribed today, TCAs remain an effective treatment option for many patients. Because these medications may affect alertness and can be harmful when taken in excessive amounts, they are often included in comprehensive drug screening panels.
Improved mood
Drowsiness
Dry mouth
Blurred vision
Constipation
Dizziness
Increased heart rate
Weight gain
Tricyclic antidepressants are generally detectable in urine for 2–7 days, depending on the specific medication, dosage, metabolism, and frequency of use.
Marijuana is a cannabis-derived substance that contains tetrahydrocannabinol (THC), the primary psychoactive compound responsible for its intoxicating effects. THC affects areas of the brain involved in memory, coordination, mood, and perception, producing both physical and psychological effects.
Marijuana is one of the most commonly detected substances in workplace, healthcare, rehabilitation, and forensic drug testing programs. Although cannabis laws vary by jurisdiction, many employers and organizations continue to include THC screening as part of their drug-free workplace policies.
Relaxation
Euphoria
Altered perception
Increased appetite
Dry mouth
Slowed reaction time
Impaired coordination
Short-term memory impairment
Frequent or heavy use may affect concentration, memory, learning ability, and overall mental health.
Weed, Marijuana, Cannabis, Pot, Ganja, Grass, Herb, Mary Jane, Hash.
THC metabolites are generally detectable in urine for 3–30 days, depending on frequency of use, body composition, metabolism, and overall health. Chronic users typically remain positive longer than occasional users.
EDDP (2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine) is the primary metabolite of methadone. Unlike methadone itself, EDDP is produced only after methadone has been processed by the body, making it an important marker for confirming methadone use.
EDDP testing is commonly used in Medication-Assisted Treatment (MAT) programs, pain management clinics, rehabilitation centers, compliance monitoring, and forensic drug testing. Screening for both Methadone (MTD) and EDDP provides a more complete assessment of methadone exposure and metabolism.
Monitoring methadone treatment compliance
Supporting Medication-Assisted Treatment (MAT) programs
Confirming methadone metabolism
Detecting potential specimen adulteration
Workplace and forensic drug screening
Pain management monitoring
Testing for EDDP helps verify that methadone has actually been metabolized by the body rather than being added directly to a urine specimen. This provides greater confidence in treatment compliance and improves the reliability of methadone monitoring programs.
For this reason, many rehabilitation centers, healthcare providers, and pain management clinics include both Methadone (MTD) and EDDP in their drug screening panels.
The 14-Panel Urine Drug Test Cup is designed to provide fast, reliable, and convenient preliminary drug screening in professional environments. Its integrated collection and testing system minimizes specimen handling while delivering accurate preliminary results in approximately 5 minutes.
Collect a fresh urine specimen directly into the collection cup.
Secure the lid firmly to help prevent leakage and contamination.
Place the cup on a clean, level surface.
Allow the test to develop without disturbing the device.
Read the results after approximately 5 minutes.
Do not interpret the results after the recommended reading time.
Following the manufacturer's testing procedure helps ensure accurate and reliable preliminary screening results
The iScreen™ Click Cup-14 Panel Urine Drug Test Cup is a professional point-of-care screening device designed to provide rapid, accurate, and convenient preliminary drug testing using human urine specimens. By combining specimen collection and testing into one self-contained device, it simplifies the screening process while minimizing specimen handling and reducing the risk of contamination.
This CLIA Waived urine drug test cup delivers reliable preliminary results in approximately 5 minutes, making it an excellent solution for routine and high-volume drug screening programs. The integrated design eliminates the need for multiple testing components while providing clear, easy-to-read results suitable for professional testing environments.
This 14-panel configuration simultaneously screens for Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BENZ), Buprenorphine (BUP), Cocaine (COC), Methamphetamine (mAMP), MDMA (Ecstasy), Methadone (MTD), Morphine/Opiates (OPI), Oxycodone (OXY), Phencyclidine (PCP), Tricyclic Antidepressants (TCA), Marijuana (THC), and EDDP (Methadone Metabolite).
The addition of EDDP, the primary metabolite of methadone, provides enhanced monitoring for methadone therapy and medication-assisted treatment (MAT) programs. Screening for both Methadone (MTD) and EDDP offers a more comprehensive assessment of methadone use and metabolism.
The self-contained collection cup helps reduce collector exposure to urine while providing dependable preliminary screening results that are easy to interpret. It is well suited for workplace drug testing, healthcare facilities, rehabilitation centers, pain management clinics, correctional facilities, occupational health programs, compliance monitoring, and forensic laboratories.
This test provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using a more specific laboratory confirmation method such as Gas Chromatography–Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)
This 14-panel urine drug test cup screens for:
This 14-panel urine drug test cup screens for the following substances:
A negative result is indicated when two colored lines appear for each drug panel—one line in the Control (C) region and one line in the Test (T) region.
Even if the Test (T) line appears faint, the result should still be interpreted as negative, indicating that the drug concentration is below the established cutoff level.
A preliminary positive result is indicated when only one colored line appears in the Control (C) region and no line appears in the Test (T) region for a particular drug.
This indicates that the concentration of the detected drug may be at or above its screening cutoff level.
Because this device provides preliminary screening results only, all positive results should be confirmed using a more specific laboratory confirmation method such as:
If the Control (C) line does not appear, the test result is invalid, regardless of whether a Test (T)** line is visible.
Invalid results may occur due to:
Repeat the test using a new device and a fresh urine specimen.
iScreen™ Click Cup-14 Panel Urine Drug Test Cup – CLIA Waived | Abbott | AMP, BAR, BENZ, BUP, COC, mAMP, MDMA, MTD, OPI, OXY, PCP, TCA, THC, EDDP | ABTDOAW114701A 25/Box
Sign up for updates from leading retailers
